Table 7.
Effect of dietary β-carotene with different supplemental levels on the content of carotenoids and retinoids in tissue sample.
| Compounds | Control | BC15 | BC30 | BC60 | BC120 |
|---|---|---|---|---|---|
| Liver (μg/g) | |||||
| β-Carotene | -1 | 1.67 ± 3.01c | 2.30 ± 0.25c | 7.97 ± 0.61b | 16.90 ± 1.64a |
| Retinol | 4.55 ± 0.41b | 5.64 ± 0.37ab | 5.72 ± 0.30a | 5.84 ± 0.48a | 4.76 ± 0.21ab |
| Retinyl palmitate | 671.86 ± 53.45d | 1009.90 ± 141.68cd | 1533.77 ± 230.92c | 2964.74 ± 189.29b | 3606.41 ± 276.08a |
| Ovary (ng/g) | |||||
| β-Carotene | -1 | 27.04 ± 1.34c | 62.00 ± 4.36c | 70.76 ± 7.34b | 179.61 ± 13.05a |
| Retinol | 193.64 ± 10.93b | 269.70 ± 14.14a | 263.27 ± 35.28a | 269.13 ± 13.24a | 265.24 ± 15.86a |
| Retinyl palmitate | 502.64 ± 85.59d | 729.68 ± 38.63cd | 853.76 ± 108.99bc | 1349.50 ± 125.22a | 1114.43 ± 85.38ab |
Means the content of β-carotene was below the limit of quantification of the detection method.
Data points with different letters are significantly different (1-way analysis of variance) at the level of P < 0.05 by Duncan's multiple comparison test.